Related Experiment Video
Updated: Jul 29, 2025

10:13
Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
2.7K
Gel-Free Tools for Quick and Simple Screening of Anti-Topoisomerase 1 Compounds
Josephine Geertsen Keller1, Kamilla Vandsø Petersen2, Karol Mizielinski1
1VPCIR Biosciences ApS, 8000 Aarhus C, Denmark.
Pharmaceuticals (Basel, Switzerland)
|May 27, 2023
Summary
New rolling circle amplification methods offer a fast and quantitative way to screen compounds targeting DNA topoisomerases. These tools aid drug discovery for cancer and infectious diseases by simplifying enzyme activity assays.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- DNA topoisomerases are crucial enzymes regulating DNA topology, making them key targets for anti-cancer, anti-bacterial, and anti-parasitic drug development.
- Existing methods for assessing topoisomerase activity and compound inhibition are often time-consuming and lack laboratory adaptability.
- There is a growing need for efficient tools to investigate biomarkers and screen potential therapeutic compounds.
Purpose of the Study:
- To develop novel, rapid, and accessible screening methods for evaluating compounds that inhibit type 1 DNA topoisomerase activity.
- To create specific assays applicable to eukaryotic, viral, and bacterial topoisomerases for broad-spectrum drug discovery.
Main Methods:
- Development and implementation of rolling circle amplification (RCA)-based assays.
- Utilized RCA for screening small-molecule compounds against various type 1 topoisomerases, including human, *Leishmania donovani*, monkeypox virus, and *Mycobacterium smegmatis* topoisomerase 1.
Main Results:
- The developed RCA-based methods provide sensitive and directly quantitative readouts for topoisomerase inhibition.
- These assays are fast and easily adaptable, overcoming limitations of current screening techniques.
- Demonstrated successful application across diverse topoisomerase targets.
Conclusions:
- The novel RCA-based tools facilitate rapid drug screening and diagnostics for topoisomerase-targeted therapies.
- These methods can accelerate the development of new treatments for cancer and infectious diseases.
- Pave the way for improved research and clinical diagnostic protocols.

